EFFECTS OF HEPARIN, DESMOPRESSIN, AND ISOVOLEMIC HEMODILUTION WITH DEXTRAN ON THROMBUS FORMATION IN SYNTHETIC VESSEL GRAFTS INSERTED INTO THE VENA-CAVA OF THE RABBIT
L. Frostarner et D. Bergqvist, EFFECTS OF HEPARIN, DESMOPRESSIN, AND ISOVOLEMIC HEMODILUTION WITH DEXTRAN ON THROMBUS FORMATION IN SYNTHETIC VESSEL GRAFTS INSERTED INTO THE VENA-CAVA OF THE RABBIT, Journal of vascular surgery, 28(3), 1998, pp. 506-513
The objective of this study was to investigate the effects of isovolem
ic hemodilution with dextran-70 on thrombus formation and blood flow i
n synthetic venous vessel grafts. Polytetrafluoroethylene grafts (leng
th, 11 mm; inner diameter, 3 mm) were inserted into the vena cava of r
abbits. Six groups were studied: (1) the control group; (2) animals th
at underwent isovolemic hemodilution with dextran-70 to a hematocrit,
of about 30%; (3) animals that underwent isovolemic dextran hemodiluti
on combined with a bolus injection of heparin; (4) animals that underw
ent heparin treatment only; (5) animals that underwent isovolemic dext
ran hemodilution combined with infusion of desmopressin; and (6) anima
ls that underwent an identical treatment to group 3 but with a 2-week,
instead of a 2-day, follow-up. Vena cava blood flow was measured befo
re and after hemodilution and graft insertion and at the termination o
f the experiments at 2 days (groups 1 to 5) and 2 weeks (group 6) afte
r surgery. Graft patency and thrombus mass weight were evaluated. In t
he control group, most of the vessels occluded within 2 days. Hemodilu
tion with dextran improved blood flow and reduced thrombus mass weight
significantly. Desmopressin, which increases factor VIII, did not inf
luence the effects of hemodilution with dextran, which suggests that t
he effects of dextran are not mediated by a reduction in the level of
this coagulation factor A single bolus dose of heparin did not reduce
thrombus formation in the grafts but did potentiate the effects of iso
volemic hemodilution on thrombus mass and graft blood flow We conclude
that isovolemic dextran hemodilution combined with a single bolus of
heparin had beneficial long-lasting effects. The grafts in groups 3 an
d 6 were all patent.